Thyronamines - Past, present, and future

S. Piehl, C. S. Hoefig, T. S. Scanlan, Josef Köhrle

Research output: Contribution to journalArticlepeer-review

104 Scopus citations


Thyronamines (TAMs) are a newly identified class of endogenous signaling compounds. Their structure is identical to that of thyroid hormone and deiodinated thyroid hormone derivatives, except that TAMs do not possess a carboxylate group. Despite some initial publications dating back to the 1950s, TAMs did not develop into an independent area of research until 2004, when they were rediscovered as potential ligands to a class of G protein-coupled receptors called trace-amine associated receptors. Since this discovery, two representatives of TAMs, namely 3-iodothyronamine (3-T 1AM) and thyronamine (T 0AM), have been detected in vivo. Intraperitoneal or central injection of 3-T 1AM or T 0AM into mice, rats, or Djungarian hamsters caused various prompt effects, such as metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria, and reduction of fat mass. Although their physiological function remains elusive, 3-T 1AM and T 0AM have already revealed promising therapeutic potential because they represent the only endogenous compounds inducing hypothermia as a prophylactic or acute treatment of stroke and might thus be expected to cause fewer side effects than synthetic compounds. This review article summarizes the still somewhat scattered data on TAMs obtained both recently and more than 20 yr ago to yield a complete and updated picture of the current state of TAM research.

Original languageEnglish (US)
Pages (from-to)64-80
Number of pages17
JournalEndocrine reviews
Issue number1
StatePublished - Feb 2011

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Thyronamines - Past, present, and future'. Together they form a unique fingerprint.

Cite this